Oversight of the new drug review process and FDA's regulation of merital : hearing before a subcommittee of the Committee on Government Operations, House of Representatives, ninety-ninth Congress, second session, May 22, 1986.
United States.Congress.House.Committee on Government Operations.
Washington : U.S.G.P.O.,
1987.
Drugs